Relmada Therapeutics Inc. (4E2)
Market Open
12 Jun, 06:03
XFRA 
€
5. 40
+0.05
+0.9346%
€
- Market Cap
- P/E Ratio
- Div Yield
470 Volume
- Eps
€ 5.35
Previous Close Want to track 4E2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
4E2 Earnings Reports FAQ
What is the earnings per share (EPS) for 4E2?
EPS data for 4E2 is currently not available, as Relmada Therapeutics Inc has not reported recent earnings.
What is the company's earnings growth rate?
Relmada Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Relmada Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Relmada Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 4E2 at this time, as Relmada Therapeutics Inc has no recent EPS data to calculate it.
